Founded in 2025, our company specializes in identifying new products with significant clinical value. We assist manufacturers who lack international sales capabilities in developing their global market presence. Simultaneously, we help clients in non-Chinese-speaking regions quickly source competitive products. Our services include product screening, quality assurance, and product certification.

Starting in 2025, we will build upon a foundation of a full range of clinical staining products to gradually develop rapid nucleic acid diagnostic systems and new cardiovascular biomarkers. We aim to address the clinical need for products that provide timely patient information, thereby effectively enhancing clinical quality.